Sun Pharmaceutical Industries, along with its subsidiaries, has settled an ongoing litigation pending in the United States District Court, District of New Jersey (Court) regarding Sun Pharma subsidiary’s generic pantoprazole.
Under the terms of the litigation settlement between Sun Pharma and Wyeth, now a division of Pfizer Inc and Atlanta Pharma AG, now known as Takeda GmbH, the parties have dismissed all their claims. Sun Pharma will pay a lump-sum $550 million as a part of this settlement. It will continue to sell its generic pantoprazole in the U.S.
Sun Pharmaceuticals Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.
